About this trial
Ablative treatments are believed to have a lower rate of complications, shorter hospital stays, and fewer interventions with benign PAD compared to partial nephrectomies in small kidney cancer lesions. The purpose of the study is to compare complications, the frequency of residual tumors, impact on kidney function, differences in quality of life, and health economic factors in a randomised study. We will also compare the oncological outcomes, including survival and recurrence of kidney cancer.
Eligibility criteria
Qualifiers
Age 18 - 99 years
Patient suitable based on clinical status for both ablative treatment and surgery
Primary kidney tumor
Tumor size ≤ 3 cm
Disqualifiers
Radiological signs of metastasis
Synchronous kidney tumors
ISUP grade IV or sarcomatoid growth in the biopsy
Other metastasized cancer in the last 5 years
Trial design
Treatments tested in this trial
- Ablation
- Surgery